Mucormycosis--from the pathogens to the disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Clinical Microbiology and Infection

• Publication date

  2014-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/1469-0691.12566PMID 24476149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutaneous mucormycosis.

  2013cited by this paper
• Epidemiology and treatment of mucormycosis.

  2013cited by this paper
• Rhinocerebral mucormycosis: literature review apropos of a rare entity

  2013cited by this paper
• Disseminated zygomycosis due to Mycocladus corymbifera with cutaneous and cerebral involvement

  2013cited by this paper
• Pulmonary mucormycosis

  2013cited by this paper
• Mucormycosis after scorpion sting: case report

  2013cited by this paper
• Infectious diseases following natural disasters: prevention and control measures

  2012cited by this paper
• Epidemiology and clinical manifestations of mucormycosis.

  2012cited by this paper
• Healthcare-associated mucormycosis.

  2012cited by this paper
• Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011.

  2012cited by this paper
• Cutaneous zygomycosis.

  2012cited by this paper
• Gastrointestinal mucormycosis—four cases with different risk factors, involving different anatomical sites

  2012cited by this paper
• Host defenses against zygomycetes.

  2012cited by this paper
• Lichtheimia Species Exhibit Differences in Virulence Potential

  2012cited by this paper
• Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

  2012cited by this paper
• Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives.

  2012cited by this paper
• Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study.

  2012cited by this paper
• Iron homeostasis—Achilles’ heel of Aspergillus fumigatus?

  2011cited by this paper
• Disseminated cutaneous mucormycosis in a patient on high-dose steroid therapy for severe ARDS

  2011cited by this paper
• Host cell invasion in mucormycosis: role of iron.

  2011influential reference
• Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009

  2011cited by this paper
• Pulmonary Mucormycosis

  2011cited by this paper
• Mucormycosis: its contemporary face and management strategies.

  2011cited by this paper
• Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases

  2011cited by this paper
• Invasive Mold Infections: Virulence and Pathogenesis of Mucorales

  2011cited by this paper
• Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.

  2011cited by this paper
• Species Recognition and Clinical Relevance of the Zygomycetous Genus Lichtheimia (syn. Absidia Pro Parte, Mycocladus)

  2010cited by this paper
• The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.

  2010cited by this paper
• Invasive cutaneous infection caused by Apophysomyces elegans associated with a spider bite

  2010cited by this paper
• The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis

  2010influential reference
• Genomic Analysis of the Basal Lineage Fungus Rhizopus oryzae Reveals a Whole-Genome Duplication

  2009cited by this paper
• The role of iron and iron chelators in zygomycosis.

  2009cited by this paper
• In vitro activity of antifungals against Zygomycetes.

  2009cited by this paper
• Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

  2009cited by this paper
• Canine ehrlichiosis in the Ivory Coast and Gabon: alteration of biochemical blood parameters based on Ehrlichia canis serology.

  2009cited by this paper
• Cutaneous zygomycosis.

  2009cited by this paper
• Safety and Outcomes of Open-Label Deferasirox Iron Chelation Therapy for Mucormycosis

  2009influential reference
• Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006

  2009cited by this paper
• Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment

  2008cited by this paper
• Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.

  2008cited by this paper
• Molecular Diagnosis of Saksenaea vasiformis Cutaneous Infection after Scorpion Sting in an Immunocompetent Adolescent

  2008cited by this paper
• Dictionary of the Fungi

  2008cited by this paper
• Host-microbe interactions: innate pattern recognition of fungal pathogens.

  2008cited by this paper
• Isolated Lingual Mucormycosis in an Infant with down Syndrome

  2008cited by this paper
• A rare case of mucormycosis of median sternotomy wound caused by Rhizopus arrhizus.

  2007cited by this paper
• The iron chelator deferasirox protects mice from mucormycosis through iron starvation.

  2007influential reference
• Gastrointestinal zygomycosis: a report of three cases

  2007cited by this paper
• Zygomycetes Hyphae Trigger an Early, Robust Proinflammatory Response in Human Polymorphonuclear Neutrophils through Toll-Like Receptor 2 Induction but Display Relative Resistance to Oxidative Damage

  2007cited by this paper
• Functional Genomics of Innate Host Defense Molecules in Normal Human Monocytes in Response to Aspergillus fumigatus

  2006cited by this paper
• Cutaneous mucormycosis in a young, immunocompetent girl.

  2006cited by this paper
• Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence.

  2006cited by this paper
• Deferasirox, an Iron-Chelating Agent, as Salvage Therapy for Rhinocerebral Mucormycosis

  2006influential reference
• Recognition of fungal pathogens by toll-like receptors.

  2006cited by this paper
• Reconstructing the early evolution of Fungi using a six-gene phylogeny

  2006cited by this paper
• Loss of the flagellum happened only once in the fungal lineage: phylogenetic structure of Kingdom Fungi inferred from RNA polymerase II subunit genes

  2006cited by this paper
• Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

  2005cited by this paper
• Rhizopus oryzae Adheres to, Is Phagocytosed by, and Damages Endothelial Cells In Vitro

  2005cited by this paper
• Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

  2005influential reference
• Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka.

  2005cited by this paper
• Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

  2005influential reference
• Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer.

  2005cited by this paper
• Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia.

  2005cited by this paper
• Facial reconstruction after mucormycosis in an immunocompetent host.

  2005cited by this paper
• Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi.

  2005cited by this paper
• Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.

  2004cited by this paper
• Recognition of fungal pathogens by Toll-like receptors

  2004cited by this paper
• Congruent evidence from α-tubulin and β-tubulin gene phylogenies for a zygomycete origin of microsporidia

  2003cited by this paper
• Congruent evidence from alpha-tubulin and beta-tubulin gene phylogenies for a zygomycete origin of microsporidia.

  2003cited by this paper
• Atlas of Clinical Fungi

  1997cited by this paper
• Ainsworth and Bisby's Dictionary of the Fungi

  1997cited by this paper
• Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine.

  1996cited by this paper
• Gastric mucormycosis.

  1994cited by this paper
• Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

  1993cited by this paper
• Gastric mucormycosis.

  1990cited by this paper
• Cutaneous mucormycosis.

  1989cited by this paper
• Pulmonary mucormycosis.

  1987cited by this paper
• In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages.

  1986cited by this paper
• Cerebral mucormycosis in diabetic mice after intrasinus challenge

  1984cited by this paper
• Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus.

  1984cited by this paper
• A Mechanism of Susceptibility to Mucormycosis in Diabetic Ketoacidosis Transferrin and Iron Availability

  1982cited by this paper
• Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis

  1982cited by this paper
• THE ZYGOMYCETE SAKSENAEA VASIFORMIS AS A PATHOGEN OF HUMANS WITH A CRITICAL REVIEW OF THE ETIOLOGY OF ZYGOMYCOSIS

  1976cited by this paper
• The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis.

  1976cited by this paper
• Ainsworth & Bisby's Dictionary of the Fungi

  1971cited by this paper

• Epimutations driven by RNAi or heterochromatin evoke transient antimicrobial drug resistance in pathogenic Mucor fungi

  2026cites this paper
• Rhino-Orbital-Cerebral Mucormycosis: An Uncommon Cause of Stroke in Young Adults

  2025cites this paper
• Impact of Anatomical Extent and Combined Surgical–Medical Therapy on Survival in Sinonasal and Rhino-Orbito-Cerebral Mucormycosis: A 14-Year Retrospective ENT Cohort

  2025cites this paper
• Novel use of hyperbaric oxygen treatment for treatment-resistant disseminated Saksenaea and Fusarium in a patient on extracorporeal membrane oxygenation (ECMO): a case report.

  2025cites this paper
• Epimutations driven by RNAi or heterochromatin evoke transient antimicrobial drug resistance in fungi

  2025cites this paper
• Oral Cavity Involvement in Mucormycosis: A Systematic Review.

  2025cites this paper
• Cytokine Profile and Oxidative Patterns in Murine Models of Disseminated Infection by Mucorales Species

  2025cites this paper
• Pulmonary mucormycosis in a young adult as a complication of a bronchopulmonary fistula

  2025cites this paper
• Invasive Gastrointestinal Mucormycosis Presenting as Neutropenic Enterocolitis: A Case Report

  2025cites this paper
• Cutaneous Mucormycosis in a Patient With Cirrhosis: A Case Report

  2025cites this paper
• Complicaciones quirúrgicas y médicas asociadas a mucormicosis en un hospital de tercer nivel

  2025cites this paper
• Fungal Dynamics in Immunocompromised Patients—A Study from a Transplant and Cancer Care Center in Western Rajasthan: A Research Article

  2025cites this paper
• Key fungal coinfections: epidemiology, mechanisms of pathogenesis, and beyond

  2025cites this paper
• Soft tissue infection of the scalp complicated by mucormycosis in an immunocompromised patient: a case report

  2024cites this paper
• Preoperative Administration of Amphotericin B in Orbital Mucormycosis Management: A Case Report

  2024cites this paper
• [Mucormycosis of the paranasal sinuses].

  2024cites this paper
• Diagnostic Challenges in Rhino-Orbito-Cerebral Mucormycosis With Diabetes Mellitus, Hypertensive Emergency, and Excess Alcohol Consumption

  2024cites this paper
• Clinical and morphological manifestation of the visceral form of candidiasis in the domestic dog (Canis familiaris)

  2024cites this paper
• Mucormycosis in a Diabetic Patient: A Case Report From Georgia

  2024cites this paper
• A Case Report on Invasive Mucormycosis Involving the Maxillary Region, Brain, and Chest

  2024cites this paper
• Longitudinal Epidemiology of Mucormycosis Within the Veterans Health Administration: A Retrospective Cohort Study Over a 20‐Year Period

  2024cites this paper
• Pulmonary mucormycosis eroding the chest wall: challenges in the management

  2024cites this paper
• Mucormicosis: un dulce enemigo, serie de casos

  2024cites this paper
• Soil as a Source of Fungi Pathogenic for Public Health

  2024cites this paper
• Getting to the Root of Dental Pain-a Hard Palate Ulcer.

  2024cites this paper
• Pathogenesis and Diagnostic Challenges of Mucormycosis

  2024cites this paper
• Mucormycosis in Diabetes

  2024cites this paper
• The unlikely suspect: A case of isolated pulmonary mucormycosis-induced acute mediastinitis in an immunocompetent patient

  2024cites this paper
• Comprehensive Review on the Virulence Factors and Therapeutic Strategies with the Aid of Artificial Intelligence against Mucormycosis.

  2024cites this paper
• Mucormycosis during COVID-19 era: A retrospective assessment

  2024cites this paper
• Mucormycosis: A Rare disease to Notifiable Disease

  2024cites this paper
• Genome-based solutions for managing mucormycosis.

  2024cites this paper
• Nitrogen-doped carbon quantum dots as a novel treatment for black fungal bone infections (Mucormycosis): in vitro and in vivo study

  2024cites this paper
• Mucormycosis Following COVID-19: A Comprehensive Case Series Investigation

  2024cites this paper
• Investigation of ternary Zn–Co–Fe layered double hydroxide as a multifunctional 2D layered adsorbent for moxifloxacin and antifungal disinfection

  2024cites this paper
• Role of Amphotericin B in the Treatment of Mucormycosis.

  2024cites this paper
• Decrypting the occurrence of mucormycosis following dental extractions: A systematic review.

  2023cites this paper
• Mucormycosis-causing fungi in humans: a meta-analysis establishing the phylogenetic relationships using internal transcribed spacer (ITS) sequences.

  2023cites this paper
• Posaconazole as single or adjunctive antifungal in mucormycosis of the maxilla: systematic review and meta-analysis

  2023cites this paper
• Complement, but Not Platelets, Plays a Pivotal Role in the Outcome of Mucormycosis In Vivo

  2023cites this paper
• Gastric Polyp

  2023cites this paper
• A rare case of pediatric gastrointestinal mucormycosis with a review of the literature

  2023cites this paper
• Antifungal Activity of Chitosan Polymeric Nanoparticles and Correlation with Their pH Against Mucor circinelloides Causing Mucormycosis, Along with Penicillium notatum and Aspergillus Species

  2023cites this paper
• Review on Mucormycosis

  2023cites this paper
• Mucormycosis, Review on Some Important Clinical Points

  2023cites this paper
• SOCIODEMOGRAPHIC AND CLINICAL PROFILE OF MUCORMYCOSIS PATIENTS ADMITTED IN TERTIARY HEALTH CARE HOSPITAL

  2023cites this paper
• COVID‐19 associated mucormycosis surge: A review on multi‐pathway mechanisms

  2023cites this paper
• Multifunctional ternary ZnMgFe LDH as an efficient adsorbent for ceftriaxone sodium and antimicrobial agent: sustainability of adsorption waste as a catalyst for methanol electro-oxidation

  2023cites this paper
• Diverse Clinical Manifestations and Challenges of Mucormycosis: Insights From Serial Cases

  2023cites this paper
• Fungal pathogens and COVID-19.

  2023cites this paper
• Emerging Polymer-Based Nanosystem Strategies in the Delivery of Antifungal Drugs

  2023cites this paper
• Rare Occurrence of Posttraumatic Cutaneous Mucormycosis After a Superficial Abrasion

  2023cites this paper
• Vitamin A Deficiency, COVID-19, and Rhino-Orbital Mycormycosis (Black Fungus): An Analytical Perspective.

  2023cites this paper
• Biosynthesis, Characterization, and Antifungal Activity of Novel Trimetallic Copper Oxide–Selenium–Zinc Oxide Nanoparticles against Some Mucorales Fungi

  2023cites this paper
• Spectrum of Fungal Infections in a Tertiary Care Centre of North India: Pre-COVID and COVID Scenario and Implications

  2023cites this paper
• Mouse Models of Mucormycosis.

  2023cites this paper
• Mucormycosis Associated with Global Coronavirus Disease-19 Pandemic: A Study of Fungal Profile from a Tertiary Health-care Center

  2023cites this paper
• Exploring the Antimicrobial Activity of Sodium Titanate Nanotube Biomaterials in Combating Bone Infections: An In Vitro and In Vivo Study

  2023cites this paper
• Mucormycosis, past and present: a comprehensive review.

  2023cites this paper
• A Comparative Overview of Various Fungal Menaces Amidst Corona Virus Disease

  2023cites this paper
• A retrospective analysis for the management of oromaxillofacial invasive mucormycosis and systematic literature review

  2023cites this paper
• Oral mucormycosis in post-COVID-19 patients: A case series

  2022cites this paper
• Mucormycosis (black fungus) and its impact on the COVID-19 patients: An updated review

  2022influential citation
• Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread

  2022cites this paper
• Emergence of mucormycosis following second wave of COVID-19 pandemic and possible risk factors in a hilly state of North India

  2022influential citation
• Hematogenous dissemination of pulmonary mucormycosis manifested as multiple subcutaneous nodules: a case report and review of the literature

  2022cites this paper
• Successful Management of Rhino-Orbital-Cerebral Mucormycosis in a Child with Acute-on-Chronic Kidney Disease and Malnutrition

  2022cites this paper
• Successful Management of Rhino-Orbital-Cerebral Mucormycosis in a 7 Child with Acute-on-Chronic Kidney Disease and Malnutrition 8 Case report and literature review

  2022cites this paper
• Görme kaybı ve serebral apse ile seyreden geç tanı konan bir rinoorbitoserebral mukormikozis olgusu

  2022cites this paper
• COVID 19 associated Rhino- Orbital- Cerebral Mucormycosis: A proposed Classification and Treatment Strategies.

  2022cites this paper
• Two Cases of Post-Traumatic Mucormycosis due to Mucor circinelloides: Salvage Therapy with a Combination of Adjunctive Therapies

  2022cites this paper
• Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis

  2022cites this paper
• Mucormycosis in Post-COVID Patients: A Review

  2022cites this paper
• Bronchial wall necrosis secondary to mucormycosis following SARS-Cov2 infection: A case report

  2022cites this paper
• Post-Covid-19 Rhino-Cerebral Mucormycosis: an Observational Study During the Second Wave.

  2022cites this paper
• Mucormycosis in the COVID-19 Environment: A Multifaceted Complication

  2022cites this paper
• Risk factor determination and qualitative risk assessment of Mucormycosis in Harbor Porpoise, an emergent fungal disease in Salish Sea marine mammals

  2022cites this paper
• Mucormycosis and role of clinical pharmacologist

  2022cites this paper
• Mucormycosis co-infection in COVID-19 patients: An update

  2022cites this paper
• Prognostication of Sino-Nasal Mucormycosis

  2022cites this paper
• Changing faces and habitat of mucormycosis epidemic in sequential COVID waves

  2022cites this paper
• Key molecules of Mucorales for COVID-19-associated mucormycosis: a narrative review

  2022cites this paper
• A case of COVID-19-associated rhino-orbito-cerebral mucormycosis caused by Apophysomyces variabilis with a review of the literature

  2022influential citation
• Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications

  2022cites this paper
• Invasive mucormycosis in a tertiary care hospital in the western region of Saudi Arabia: 11-year retrospective chart review from 2009 to 2019.

  2022cites this paper
• Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19

  2022cites this paper
• Parietal composition of Lichtheimia corymbifera: differences between spore and germ tube stages and host-pathogen interactions.

  2022cites this paper
• Mucormycosis.

  2021cites this paper
• Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes

  2021cites this paper
• A comprehensive review of pathogenesis of mucormycosis with implications of COVID-19: Indian perspective

  2021cites this paper
• Hepatic failure and malnutrition as predisposing factors of cutaneous mucormycosis in a pediatric patient

  2021cites this paper
• Black Fungus an Add on Epidemic to Cosvid-19 Pandemic

  2021cites this paper
• Brain abscess due to the Mucoraceae in a renal transplant recipient; successful endoscopic treatment

  2021cites this paper
• New insights on mucormycosis and its association with the COVID-19 pandemic

  2021cites this paper
• Cutaneous Mucormycosis of the Interscapular Region in an Immunocompetent Patient

  2021cites this paper
• COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis

  2021cites this paper
• Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics To Design Selective and Nonimmunosuppressive FK506 Analogs

  2021cites this paper
• A Proposed Grading System and Experience of COVID-19 Associated Rhino Orbito Cerebral Mucormycosis from an Indian Tertiary Care Center

  2021cites this paper
• Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario

  2021cites this paper
• Drug Repurposing: In Silico Modeling of Mucor Mycosis

  2021cites this paper